本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cogent Biosciences, Inc.

32.74
-0.6700-2.01%
盤後32.910.1700+0.52%19:48 EDT
成交量:171.24萬
成交額:5,647.77萬
市值:56.81億
市盈率:-15.16
高:33.93
開:33.37
低:32.69
收:33.41
52周最高:43.73
52周最低:11.60
股本:1.74億
流通股本:1.67億
量比:0.93
換手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
淨資產收益率:-109.74%
總資產收益率:-43.84%
市淨率:12.15
市盈率(LYR):-12.84

資料載入中...

2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/25

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/27

重要事件披露

8-K - Current report
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/17

重要事件披露

8-K - Current report
2021/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/12

重要事件披露

8-K - Current report
2021/03/16

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/16

重要事件披露

8-K - Current report
2021/02/22

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals